Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 14Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Colorectal Neoplasms 9Prostatic Neoplasms 8Lung Neoplasms 7Melanoma 6Pancreatic Neoplasms 5Head and Neck Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neoplastic Cells, Circulating 4Hematologic Neoplasms 4Stomach Neoplasms 3Neoplasm Metastasis 3Leukemia, Myeloid, Acute 3Leukemia 3Glioblastoma 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Sarcoma 2Recurrence 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Liver Diseases 2Kidney Neoplasms 2Glioma 2Fibrosis 2

Interventions

Radiation Dose Hypofractionation 2toripalimab 1lentiviral minigene vaccine of COVID-19 coronavirus 1envafolimab 1brostallicin 1anlotinib 1Temozolomide 1Ritonavir 1Radiotherapy 1Phlebotomy 1Molecular Diagnostic Techniques 1Microarray Analysis 1Ipilimumab 1Indinavir 1Doxorubicin 1Diathermy 1Blood Specimen Collection 1Biopsy, Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Histiocytoma, Malignant Fibrous × Blood Specimen Collection × Clear all
NCT03946943 2019-07-10

Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma

The First Hospital of Jilin University

Phase 2 Unknown
25 enrolled
Sarcoma

Sarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡